Vol. 1 No. Suppl 2 (2025): Tissue Repair Evidence Summit Abstracts

Published: 2025-10-27

Abstracts

Evaluation of intact fish skin grafts plus standard care in the treatment of venous leg ulcers: an interim analysis of the THOR trial

Thomas E Serena, Brianna Tramelli, Barkley Booker, Emily King, Dereck Shi, John C Lantis (Author)
- PDF
Evaluation of dual layer amnion patch on the healing rate of chronic diabetic foot ulcers: an interim analysis of the Med-Maxx SG trial

Thomas E Serena, Brianna Tramelli, Zwelithini Tunyiswa, Nicole Schrecengost (Author)
- PDF
Evaluation of acellular human dermis graft on the healing rate of chronic diabetic foot ulcers: an interim analysis of the Derm-Maxx trial

Thomas E Serena, Brianna Tramelli, Zwelithini Tunyiswa (Author)
- PDF
Real-world evaluation of cellular, acellular, and matrix-like products for pressure ulcers in the post-acute setting

ZWELITHINI TUNYISWA, Ryan Dirks, Howard Walthall (Author)
- PDF
A systematic review with semi-quantitative synthesis and GRADE qualification of the effectiveness of a keratin-based matrix in treating hard-to-heal wounds

William Tettelbach, Martha R Kelso, Louis Cappa, Mervin Low (Author)
- PDF
Full thickness placental membrane allograft for diabetic foot ulcers: two clinical cases from the TIGERCAMP clinical trial

Thomas E Serena, Ekaterina Chashnikova, Brianna Tramelli, Emily King, Dereck Shi, Gregory Bohn, Henry Ohse (Author)
- PDF
A multicenter, prospective randomized controlled modified dual platform trial evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the management of nonhealing diabetic foot ulcers and venous leg ulcers (TIGERCAMP)

Thomas E Serena, Brianna Tramelli, Emily King (Author)
- PDF
Evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care in the management of non-healing pressure ulcers using matched controls: a randomized controlled modified platform trial

Thomas E Serena, Brianna Tramelli, Emily King, Ekaterina Chashnikova (Author)
- PDF
Evaluation of amnion chorion amnion placental allograft in the management of nonhealing diabetic foot ulcers and venous leg ulcers: a preliminary case series of the TIGERCAMP clinical trial

Thomas E Serena, Siobhan McGurk, Brianna Tramelli, Emily King, Dereck Shi, Gregory Bohn, Henry Ohse (Author)
- PDF
Evaluation of CompleteFT^TM placental allograft in clinical practice across wound etiologies

Naz Wahab (Author)
- PDF
A prospective, multicenter, randomized, controlled trial of non-healingdiabetic foot ulcers treated with standard care with or without br-ac: top-line results

Herbert Slade, Nick McCoy, Wendy W Weston, Zwelithini Tunyiswa (Author)
- PDF
Comparative outcomes of a placenta-based tissue product to other LCD covered cellular and matrix-based products for the treatment of lower extremity diabetic ulcers: A Medicare real world evidence study

William Tettelbach, Travis Tucker, Kimberly Kot (Author)
- PDF
Comparative health resource utilization and cost analysis of porcine placental extracellular matrix versus standard of care and other advanced treatments in the treatment of diabetic foot ulcers in the Medicare Fee-For-Service population

Jenny Levinson, Janet Mackenzie, Rebecca Decker, Serena Nally, Irene Varghese, Caitlin Sheetz, Peter Kardel, Cristin Taylor (Author)
- PDF
Evaluation of multiple cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the treatment of nonhealing diabetic foot ulcers: an interim analysis of the CAMPFIRE clinical trial

Thomas E Serena, Brianna Tramelli, Stephanie Wilkins, Zwelithini Tunyiswa (Author)
- PDF
Efficacy of placental derived allografts and standard of care in the treatment of nonhealing diabetic foot ulcers using matched controls: a randomized controlled trial

Thomas E Serena, Brianna Tramelli, Emily King (Author)
- PDF
Evaluation of lyophilized human amnion/chorion membrane (LHACM) in the management of nonhealing diabetic foot ulcers: an interim analysis of the CAMPAIGN trial

Thomas E Serena, Brianna Tramelli, Brittany Bonafide, Zwelithini Tunyiswa (Author)
- PDF
Real world evidence retrospective study to evaluate the safety and efficacy of an amniotic membrane allograft for venous leg ulcers in a post-acute care setting

Ayesha Qadeer, Emaad Basith, Martha R Kelso, Saad Mohsin, Rashad Sayeed (Author)
- PDF
Real world evidence retrospective study to evaluate the safety and efficacy of an amniotic membrane allograft for lower extremity diabetic ulcers in a post-acute care setting

Ayesha Qadeer, Emaad Basith, Martha R Kelso, Saad Mohsin, Rashad Sayeed (Author)
- PDF
Comparative health resource utilization and cost analysis of porcine placental extracellular matrix versus standard of care and other advanced treatments in the treatment of venous leg ulcers in the Medicare Fee-For-Service population

Jenny Levinson, Janet Mackenzie, Rebecca Decker, Serena Nally, Irene Varghese, Caitlin Sheetz, Peter Kardel, Cristin Taylor (Author)
- PDF
Evaluation of cellular, acellular, and matrix-like products (CAMPs) in the management of nonhealing diabetic foot ulcers: an interim analysis of the STABLECAMP trial

Thomas E Serena, Brianna Tramelli, Emily King, Dereck Shi, Madison Dunn, Manisha Mehta, David Simon, R Andrew Pavelescu (Author)
- PDF
Evaluation of cellular, acellular, and matrix-like products in the management of nonhealing venous leg ulcers: an interim analysis of STABLECAMP

Thomas E Serena, Brianna Tramelli, Madison Dunn, Emily King, Dereck Shi (Author)
- PDF
Evaluation of single layer amniotic membrane in the management of nonhealing diabetic foot ulcers: an interim analysis of CAMPX

Thomas E Serena, Brianna Tramelli, Emily King, Dereck Shi, Gregory Bohn, Ryan Breisinger (Author)
- PDF
Evaluation of human placental-based cellular, acellular and matrix-like products (CAMPs) in the management of nonhealing diabetic foot ulcers: an interim analysis of the CAMPSTIM clinical trial

Thomas E Serena, Brianna Tramelli, Emily King, Dereck Shi, Kristy Breisinger, Meghan Neil, Stephen Frania, William Namen, Keyur Patel, Mohammad Salameh, Glenn York, George Silver, Sherocko Gatlin-James, Michael Calderone, Rami Shaarawy (Author)
- PDF

Vol. 1 No. Suppl 2 (2025): Tissue Repair Evidence Summit Abstracts

Abstracts

Evaluation of intact fish skin grafts plus standard care in the treatment of venous leg ulcers: an interim analysis of the THOR trial

Evaluation of dual layer amnion patch on the healing rate of chronic diabetic foot ulcers: an interim analysis of the Med-Maxx SG trial

Evaluation of acellular human dermis graft on the healing rate of chronic diabetic foot ulcers: an interim analysis of the Derm-Maxx trial

Real-world evaluation of cellular, acellular, and matrix-like products for pressure ulcers in the post-acute setting

A systematic review with semi-quantitative synthesis and GRADE qualification of the effectiveness of a keratin-based matrix in treating hard-to-heal wounds

Full thickness placental membrane allograft for diabetic foot ulcers: two clinical cases from the TIGERCAMP clinical trial

A multicenter, prospective randomized controlled modified dual platform trial evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the management of nonhealing diabetic foot ulcers and venous leg ulcers (TIGERCAMP)

Evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care in the management of non-healing pressure ulcers using matched controls: a randomized controlled modified platform trial

Evaluation of amnion chorion amnion placental allograft in the management of nonhealing diabetic foot ulcers and venous leg ulcers: a preliminary case series of the TIGERCAMP clinical trial

Evaluation of CompleteFT^TM placental allograft in clinical practice across wound etiologies

A prospective, multicenter, randomized, controlled trial of non-healingdiabetic foot ulcers treated with standard care with or without br-ac: top-line results

Comparative outcomes of a placenta-based tissue product to other LCD covered cellular and matrix-based products for the treatment of lower extremity diabetic ulcers: A Medicare real world evidence study

Comparative health resource utilization and cost analysis of porcine placental extracellular matrix versus standard of care and other advanced treatments in the treatment of diabetic foot ulcers in the Medicare Fee-For-Service population

Evaluation of multiple cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the treatment of nonhealing diabetic foot ulcers: an interim analysis of the CAMPFIRE clinical trial

Efficacy of placental derived allografts and standard of care in the treatment of nonhealing diabetic foot ulcers using matched controls: a randomized controlled trial

Evaluation of lyophilized human amnion/chorion membrane (LHACM) in the management of nonhealing diabetic foot ulcers: an interim analysis of the CAMPAIGN trial

Real world evidence retrospective study to evaluate the safety and efficacy of an amniotic membrane allograft for venous leg ulcers in a post-acute care setting

Real world evidence retrospective study to evaluate the safety and efficacy of an amniotic membrane allograft for lower extremity diabetic ulcers in a post-acute care setting

Comparative health resource utilization and cost analysis of porcine placental extracellular matrix versus standard of care and other advanced treatments in the treatment of venous leg ulcers in the Medicare Fee-For-Service population

Evaluation of cellular, acellular, and matrix-like products (CAMPs) in the management of nonhealing diabetic foot ulcers: an interim analysis of the STABLECAMP trial

Evaluation of cellular, acellular, and matrix-like products in the management of nonhealing venous leg ulcers: an interim analysis of STABLECAMP

Evaluation of single layer amniotic membrane in the management of nonhealing diabetic foot ulcers: an interim analysis of CAMPX

Evaluation of human placental-based cellular, acellular and matrix-like products (CAMPs) in the management of nonhealing diabetic foot ulcers: an interim analysis of the CAMPSTIM clinical trial

Information

Make a Submission